Israel Active

Researchers from four Israeli medical institutes have identified early signs in the body that indicate breast cancer is about to spread to other organs. The discovery could save millions of lives. They also discovered that the protein MYC speeds the growth of cancerous cells.

A successful Israeli trial of Covid-19 treatment EXO-CD24 (see previously) has now been reinforced by a trial on 88 patients in Greece. 90% of the moderate and serious patients (aged up to 85) were released within five days of treatment. None required to be put on ventilators.

Having watched his father save many lives as a volunteer EMT for Israel’s United Hatzalah, 16-year-old Shaked decided to learn how to administer CPR himself. So, when bystanders didn’t know what to do when a woman collapsed in Afula, Shaked stepped right up and saved her life.

The Israel Cancer Research Fund is holding a virtual gala on 10th Aug to raise funds to help the most promising Israeli scientists advance ways to prevent, diagnose and treat cancer. ICRF has already provided more than 2,500 grants that have been responsible for major cancer research breakthroughs.

Israel-based RealView Imaging (see previously) has received FDA clearance for its HOLOSCOPE-i holographic system. The system creates spatially accurate, 3D interactive medical holograms, based on data received from standard CT scans and 3D ultrasound systems.

Israel’s CardiacSense (see previously) is about to ship its first heart-monitoring smartwatches around the world. This article gives the history and technical details of the low-cost product that can save many lives, at a fraction of the cost of hospital sensors and implants.

Honest Reporting’s Daniel Pomerantz was interviewed on Turkish TV about Israel’s coronavirus activities. He revealed that President Isaac Herzog was one of the first to receive a third (booster) vaccination against SARS-Cov-2. It was administered at Sheba hospital by Muslim Arab nurse Lina Ahmad.

Israel’s Append Medical is developing the Appligator - an implantable device for closing the Left Atrial Appendix (LAA) to prevent blood clot leakage and strokes in those suffering from atrial fibrillation (AF). However, unlike other implants, the device is removed after surgery, leaving just stitches.

It is known that a build-up of Amyloid plaques in the brain is common in Alzheimer’s patients, but what do they affect? Scientists at Israel’s Ben Gurion University have just found that they are a catalyst to the degradation of neurotransmitters such as dopamine and adrenaline.

A US clinical study involving Irving Weissman of Ben Gurion University is using the antibody Magrolimab to enhance “scavenger macrophages” - cancer cell-eating white blood cells. Magrolimab blocks the CD47 molecule that cancer cells produce to signal “don’t eat me” to the macrophages.